Since the development of DMT2 and CKD is often associated with insulin resistance, it has been suggested that irisin may play an important role in the pathology of insulin-resistance related disorders while it may provide a novel therapeutic target for the treatment of metabolic diseases [18, 32, 35]. Here, FNDC5 is linked to Insulin resistance.